Since January 2021, PAA stock has returned 85% to shareholders. But if we adjust for dividend reinvestments, cumulative ...

Pfizer remains a Strong Buy, with oncology breakthroughs, a revitalized obesity pipeline, and aggressive cost savings ...

Pfizer Inc. (NYSE: PFE) is included among the 13 Best Dividend Stocks Paying Over 6%.

Diversification is key to successful long-term investing. In other words, don't put all your eggs in one basket.

Diversification is key to successful long-term investing. In other words, don't put all your eggs in one basket.

Royalty Pharma plc (Nasdaq: RPRX) today announced that its board of directors has declared a dividend for the first quarter of 2026 of $0.235 per Class A ordinary share, reflecting a 6.8% increase in ...

Dow Jones Industrial Average, Chevron Corp, Coca-Cola Co, Merck & Company Inc. Read 's Market Analysis on Investing.com ...

These five high-yield dividend stocks with solid upside potential and Buy ratings make sense for growth and income investors ...

Despite additional cost savings in 2026, Pfizer also forecasts that its adjusted earnings per share (EPS) will likely decline ...

Since consumer spending accounts for about 70% of U.S. GDP, lower outlays by the working class and the middle class could cause economic growth to decelerate sharply in 2026. Additionally, AI stocks’ ...

Pfizer's 2026 revenue midpoint of $61B and EPS midpoint of $2.90 decline YoY, reflecting persisting headwinds. Read more on ...